Compassus - Greater Connecticut Medicare Approved Location: 109 Boston Post Road, Suite 202-203, Orange, Connecticut 06477 Phone: (203) 301-0489 |
Constellation Hospice Medicare Approved Location: 240 Indian River Road, Orange, Connecticut 06477 Phone: (203) 497-3888 |
News Archive
An analysis of data from 10 studies indicates that the presence of low frequency (also called "minority") human immunodeficiency virus type 1 (HIV-1) drug resistance mutations, particularly those involving nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance, are significantly associated with an increased risk of first-line antiretroviral treatment failure, according to an article in the April 6 issue of JAMA.
In early April, YouTube took down a video featuring Florida Gov. Ron DeSantis and a group of controversial scientists at a March 18 coronavirus roundtable. The online video platform, owned by Google, cited as its rationale that the video contained false statements about the efficacy of children's mask-wearing.
Opexa Therapeutics, Inc., announced today that its lead drug candidate Tovaxin® has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with Secondary Progressive Multiple Sclerosis.
The advances in treating childhood leukaemia over the last forty years have been one of cancer's outstanding success stories – but the fall in mortality has diverted attention from a rise in incidence, a London conference will hear today (Monday 6 September).
› Verified 9 days ago